nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Methylprednisolone—ankylosing spondylitis	0.14	0.167	CbGbCtD
Ticagrelor—ABCB1—Betamethasone—ankylosing spondylitis	0.0913	0.108	CbGbCtD
Ticagrelor—ABCB1—Prednisolone—ankylosing spondylitis	0.0901	0.107	CbGbCtD
Ticagrelor—ABCB1—Prednisone—ankylosing spondylitis	0.0851	0.101	CbGbCtD
Ticagrelor—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0841	0.0999	CbGbCtD
Ticagrelor—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0637	0.0757	CbGbCtD
Ticagrelor—CYP3A4—Betamethasone—ankylosing spondylitis	0.0547	0.065	CbGbCtD
Ticagrelor—CYP3A4—Prednisolone—ankylosing spondylitis	0.054	0.0641	CbGbCtD
Ticagrelor—ABCB1—Dexamethasone—ankylosing spondylitis	0.0531	0.0631	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—ankylosing spondylitis	0.051	0.0605	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—ankylosing spondylitis	0.0427	0.0507	CbGbCtD
Ticagrelor—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0318	0.0378	CbGbCtD
Ticagrelor—Petechiae—Prednisone—ankylosing spondylitis	0.00117	0.00742	CcSEcCtD
Ticagrelor—Haematemesis—Methotrexate—ankylosing spondylitis	0.00116	0.00734	CcSEcCtD
Ticagrelor—Lung disorder—Methotrexate—ankylosing spondylitis	0.00114	0.00721	CcSEcCtD
Ticagrelor—Contusion—Prednisone—ankylosing spondylitis	0.00111	0.007	CcSEcCtD
Ticagrelor—Ecchymosis—Triamcinolone—ankylosing spondylitis	0.0011	0.00699	CcSEcCtD
Ticagrelor—Ecchymosis—Methylprednisolone—ankylosing spondylitis	0.0011	0.00697	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.00106	0.00673	CcSEcCtD
Ticagrelor—Ecchymosis—Dexamethasone—ankylosing spondylitis	0.001	0.00634	CcSEcCtD
Ticagrelor—Ecchymosis—Betamethasone—ankylosing spondylitis	0.001	0.00634	CcSEcCtD
Ticagrelor—Petechiae—Methotrexate—ankylosing spondylitis	0.00098	0.0062	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.000977	0.00618	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.000975	0.00617	CcSEcCtD
Ticagrelor—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.000906	0.00573	CcSEcCtD
Ticagrelor—Bone disorder—Methotrexate—ankylosing spondylitis	0.000893	0.00565	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000887	0.00561	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000887	0.00561	CcSEcCtD
Ticagrelor—Oliguria—Methotrexate—ankylosing spondylitis	0.000875	0.00554	CcSEcCtD
Ticagrelor—Ecchymosis—Prednisone—ankylosing spondylitis	0.000872	0.00552	CcSEcCtD
Ticagrelor—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.000869	0.0055	CcSEcCtD
Ticagrelor—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.000824	0.00521	CcSEcCtD
Ticagrelor—Cardiac failure—Betamethasone—ankylosing spondylitis	0.000824	0.00521	CcSEcCtD
Ticagrelor—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.000821	0.0052	CcSEcCtD
Ticagrelor—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000799	0.00506	CcSEcCtD
Ticagrelor—Melaena—Methotrexate—ankylosing spondylitis	0.000788	0.00498	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000772	0.00489	CcSEcCtD
Ticagrelor—Ecchymosis—Methotrexate—ankylosing spondylitis	0.000729	0.00461	CcSEcCtD
Ticagrelor—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.000722	0.00457	CcSEcCtD
Ticagrelor—Cardiac failure—Prednisone—ankylosing spondylitis	0.000718	0.00454	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.0007	0.00443	CcSEcCtD
Ticagrelor—Bradycardia—Prednisolone—ankylosing spondylitis	0.000679	0.0043	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00067	0.00424	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000667	0.00422	CcSEcCtD
Ticagrelor—Epistaxis—Triamcinolone—ankylosing spondylitis	0.000644	0.00408	CcSEcCtD
Ticagrelor—Renal failure acute—Methotrexate—ankylosing spondylitis	0.000634	0.00401	CcSEcCtD
Ticagrelor—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000624	0.00395	CcSEcCtD
Ticagrelor—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000623	0.00394	CcSEcCtD
Ticagrelor—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000616	0.0039	CcSEcCtD
Ticagrelor—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000615	0.00389	CcSEcCtD
Ticagrelor—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000613	0.00388	CcSEcCtD
Ticagrelor—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000612	0.00387	CcSEcCtD
Ticagrelor—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000601	0.0038	CcSEcCtD
Ticagrelor—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000572	0.00362	CcSEcCtD
Ticagrelor—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000568	0.00359	CcSEcCtD
Ticagrelor—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000566	0.00358	CcSEcCtD
Ticagrelor—Bradycardia—Betamethasone—ankylosing spondylitis	0.000566	0.00358	CcSEcCtD
Ticagrelor—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000559	0.00354	CcSEcCtD
Ticagrelor—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000559	0.00354	CcSEcCtD
Ticagrelor—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000556	0.00352	CcSEcCtD
Ticagrelor—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000556	0.00352	CcSEcCtD
Ticagrelor—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000555	0.00351	CcSEcCtD
Ticagrelor—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000553	0.0035	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000551	0.00349	CcSEcCtD
Ticagrelor—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000536	0.00339	CcSEcCtD
Ticagrelor—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000533	0.00337	CcSEcCtD
Ticagrelor—Angioedema—Prednisolone—ankylosing spondylitis	0.00053	0.00336	CcSEcCtD
Ticagrelor—Breast disorder—Methotrexate—ankylosing spondylitis	0.000529	0.00335	CcSEcCtD
Ticagrelor—Vertigo—Prednisolone—ankylosing spondylitis	0.000522	0.0033	CcSEcCtD
Ticagrelor—Syncope—Prednisolone—ankylosing spondylitis	0.000521	0.00329	CcSEcCtD
Ticagrelor—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00052	0.00329	CcSEcCtD
Ticagrelor—Eye disorder—Betamethasone—ankylosing spondylitis	0.00052	0.00329	CcSEcCtD
Ticagrelor—Back pain—Triamcinolone—ankylosing spondylitis	0.000516	0.00327	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00051	0.00323	CcSEcCtD
Ticagrelor—Angiopathy—Betamethasone—ankylosing spondylitis	0.000505	0.00319	CcSEcCtD
Ticagrelor—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000505	0.00319	CcSEcCtD
Ticagrelor—Hypertension—Prednisolone—ankylosing spondylitis	0.000501	0.00317	CcSEcCtD
Ticagrelor—Bradycardia—Prednisone—ankylosing spondylitis	0.000493	0.00312	CcSEcCtD
Ticagrelor—Angioedema—Triamcinolone—ankylosing spondylitis	0.000488	0.00309	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisone—ankylosing spondylitis	0.000487	0.00308	CcSEcCtD
Ticagrelor—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000487	0.00308	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—ankylosing spondylitis	0.000485	0.00307	CcSEcCtD
Ticagrelor—Vertigo—Triamcinolone—ankylosing spondylitis	0.00048	0.00303	CcSEcCtD
Ticagrelor—Syncope—Triamcinolone—ankylosing spondylitis	0.000479	0.00303	CcSEcCtD
Ticagrelor—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000479	0.00303	CcSEcCtD
Ticagrelor—Syncope—Methylprednisolone—ankylosing spondylitis	0.000478	0.00302	CcSEcCtD
Ticagrelor—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000476	0.00301	CcSEcCtD
Ticagrelor—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000469	0.00297	CcSEcCtD
Ticagrelor—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000468	0.00296	CcSEcCtD
Ticagrelor—Shock—Prednisolone—ankylosing spondylitis	0.000466	0.00295	CcSEcCtD
Ticagrelor—Cough—Triamcinolone—ankylosing spondylitis	0.000466	0.00295	CcSEcCtD
Ticagrelor—Hypertension—Triamcinolone—ankylosing spondylitis	0.000461	0.00292	CcSEcCtD
Ticagrelor—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00046	0.00291	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—ankylosing spondylitis	0.000453	0.00287	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00045	0.00285	CcSEcCtD
Ticagrelor—Angioedema—Dexamethasone—ankylosing spondylitis	0.000443	0.0028	CcSEcCtD
Ticagrelor—Angioedema—Betamethasone—ankylosing spondylitis	0.000443	0.0028	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—ankylosing spondylitis	0.00044	0.00278	CcSEcCtD
Ticagrelor—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000438	0.00277	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—ankylosing spondylitis	0.000438	0.00277	CcSEcCtD
Ticagrelor—Vertigo—Dexamethasone—ankylosing spondylitis	0.000435	0.00275	CcSEcCtD
Ticagrelor—Vertigo—Betamethasone—ankylosing spondylitis	0.000435	0.00275	CcSEcCtD
Ticagrelor—Syncope—Betamethasone—ankylosing spondylitis	0.000434	0.00275	CcSEcCtD
Ticagrelor—Syncope—Dexamethasone—ankylosing spondylitis	0.000434	0.00275	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—ankylosing spondylitis	0.00043	0.00272	CcSEcCtD
Ticagrelor—Shock—Triamcinolone—ankylosing spondylitis	0.000429	0.00271	CcSEcCtD
Ticagrelor—Shock—Methylprednisolone—ankylosing spondylitis	0.000428	0.00271	CcSEcCtD
Ticagrelor—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000426	0.0027	CcSEcCtD
Ticagrelor—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000426	0.00269	CcSEcCtD
Ticagrelor—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000426	0.00269	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—ankylosing spondylitis	0.000426	0.00269	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000425	0.00269	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—ankylosing spondylitis	0.000425	0.00269	CcSEcCtD
Ticagrelor—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000422	0.00267	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—ankylosing spondylitis	0.000422	0.00267	CcSEcCtD
Ticagrelor—Hypertension—Dexamethasone—ankylosing spondylitis	0.000418	0.00265	CcSEcCtD
Ticagrelor—Hypertension—Betamethasone—ankylosing spondylitis	0.000418	0.00265	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000407	0.00258	CcSEcCtD
Ticagrelor—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000406	0.00257	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000405	0.00256	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.0004	0.00253	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000397	0.00251	CcSEcCtD
Ticagrelor—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000391	0.00248	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00039	0.00247	CcSEcCtD
Ticagrelor—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00039	0.00247	CcSEcCtD
Ticagrelor—Shock—Betamethasone—ankylosing spondylitis	0.000389	0.00246	CcSEcCtD
Ticagrelor—Shock—Dexamethasone—ankylosing spondylitis	0.000389	0.00246	CcSEcCtD
Ticagrelor—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000388	0.00246	CcSEcCtD
Ticagrelor—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000388	0.00245	CcSEcCtD
Ticagrelor—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000388	0.00245	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—ankylosing spondylitis	0.000385	0.00244	CcSEcCtD
Ticagrelor—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000384	0.00243	CcSEcCtD
Ticagrelor—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000383	0.00242	CcSEcCtD
Ticagrelor—Vertigo—Prednisone—ankylosing spondylitis	0.000379	0.0024	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—ankylosing spondylitis	0.000378	0.00239	CcSEcCtD
Ticagrelor—Syncope—Prednisone—ankylosing spondylitis	0.000378	0.00239	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000376	0.00238	CcSEcCtD
Ticagrelor—Fatigue—Triamcinolone—ankylosing spondylitis	0.000376	0.00238	CcSEcCtD
Ticagrelor—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000375	0.00237	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000371	0.00235	CcSEcCtD
Ticagrelor—Hypotension—Dexamethasone—ankylosing spondylitis	0.000369	0.00234	CcSEcCtD
Ticagrelor—Hypotension—Betamethasone—ankylosing spondylitis	0.000369	0.00234	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—ankylosing spondylitis	0.000367	0.00232	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000366	0.00231	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000365	0.00231	CcSEcCtD
Ticagrelor—Hypertension—Prednisone—ankylosing spondylitis	0.000364	0.0023	CcSEcCtD
Ticagrelor—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000359	0.00227	CcSEcCtD
Ticagrelor—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000358	0.00227	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000357	0.00226	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000355	0.00225	CcSEcCtD
Ticagrelor—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000355	0.00225	CcSEcCtD
Ticagrelor—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000355	0.00225	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—ankylosing spondylitis	0.000355	0.00224	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—ankylosing spondylitis	0.000353	0.00223	CcSEcCtD
Ticagrelor—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000349	0.00221	CcSEcCtD
Ticagrelor—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000348	0.0022	CcSEcCtD
Ticagrelor—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000348	0.0022	CcSEcCtD
Ticagrelor—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000344	0.00218	CcSEcCtD
Ticagrelor—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000344	0.00217	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Ticagrelor—Fatigue—Betamethasone—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Ticagrelor—Fatigue—Dexamethasone—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Ticagrelor—Shock—Prednisone—ankylosing spondylitis	0.000339	0.00214	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000338	0.00214	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—ankylosing spondylitis	0.000334	0.00212	CcSEcCtD
Ticagrelor—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000326	0.00206	CcSEcCtD
Ticagrelor—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000326	0.00206	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000323	0.00205	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000323	0.00205	CcSEcCtD
Ticagrelor—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000321	0.00203	CcSEcCtD
Ticagrelor—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00032	0.00203	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—ankylosing spondylitis	0.000317	0.002	CcSEcCtD
Ticagrelor—Dizziness—Prednisolone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Asthenia—Triamcinolone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Ticagrelor—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000312	0.00197	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisone—ankylosing spondylitis	0.000309	0.00196	CcSEcCtD
Ticagrelor—Pruritus—Triamcinolone—ankylosing spondylitis	0.000308	0.00195	CcSEcCtD
Ticagrelor—Cough—Methotrexate—ankylosing spondylitis	0.000308	0.00195	CcSEcCtD
Ticagrelor—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000308	0.00195	CcSEcCtD
Ticagrelor—Dyspepsia—Prednisone—ankylosing spondylitis	0.000303	0.00192	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—ankylosing spondylitis	0.0003	0.0019	CcSEcCtD
Ticagrelor—Rash—Prednisolone—ankylosing spondylitis	0.000299	0.00189	CcSEcCtD
Ticagrelor—Dermatitis—Prednisolone—ankylosing spondylitis	0.000298	0.00189	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000298	0.00189	CcSEcCtD
Ticagrelor—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000297	0.00188	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—ankylosing spondylitis	0.000297	0.00188	CcSEcCtD
Ticagrelor—Headache—Prednisolone—ankylosing spondylitis	0.000297	0.00188	CcSEcCtD
Ticagrelor—Constipation—Prednisone—ankylosing spondylitis	0.000294	0.00186	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—ankylosing spondylitis	0.00029	0.00184	CcSEcCtD
Ticagrelor—Dizziness—Triamcinolone—ankylosing spondylitis	0.000288	0.00182	CcSEcCtD
Ticagrelor—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000287	0.00182	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000284	0.0018	CcSEcCtD
Ticagrelor—Asthenia—Dexamethasone—ankylosing spondylitis	0.000284	0.00179	CcSEcCtD
Ticagrelor—Asthenia—Betamethasone—ankylosing spondylitis	0.000284	0.00179	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000282	0.00179	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000282	0.00178	CcSEcCtD
Ticagrelor—Nausea—Prednisolone—ankylosing spondylitis	0.000281	0.00178	CcSEcCtD
Ticagrelor—Pruritus—Dexamethasone—ankylosing spondylitis	0.00028	0.00177	CcSEcCtD
Ticagrelor—Pruritus—Betamethasone—ankylosing spondylitis	0.00028	0.00177	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—ankylosing spondylitis	0.000279	0.00177	CcSEcCtD
Ticagrelor—Vomiting—Triamcinolone—ankylosing spondylitis	0.000277	0.00175	CcSEcCtD
Ticagrelor—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000276	0.00175	CcSEcCtD
Ticagrelor—Rash—Triamcinolone—ankylosing spondylitis	0.000275	0.00174	CcSEcCtD
Ticagrelor—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000274	0.00174	CcSEcCtD
Ticagrelor—Rash—Methylprednisolone—ankylosing spondylitis	0.000274	0.00173	CcSEcCtD
Ticagrelor—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000274	0.00173	CcSEcCtD
Ticagrelor—Headache—Triamcinolone—ankylosing spondylitis	0.000273	0.00173	CcSEcCtD
Ticagrelor—Headache—Methylprednisolone—ankylosing spondylitis	0.000272	0.00172	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—ankylosing spondylitis	0.000272	0.00172	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—ankylosing spondylitis	0.000272	0.00172	CcSEcCtD
Ticagrelor—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00027	0.00171	CcSEcCtD
Ticagrelor—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00027	0.00171	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—ankylosing spondylitis	0.000269	0.0017	CcSEcCtD
Ticagrelor—Dizziness—Betamethasone—ankylosing spondylitis	0.000261	0.00165	CcSEcCtD
Ticagrelor—Dizziness—Dexamethasone—ankylosing spondylitis	0.000261	0.00165	CcSEcCtD
Ticagrelor—Nausea—Triamcinolone—ankylosing spondylitis	0.000259	0.00164	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000258	0.00163	CcSEcCtD
Ticagrelor—Nausea—Methylprednisolone—ankylosing spondylitis	0.000258	0.00163	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000257	0.00162	CcSEcCtD
Ticagrelor—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000254	0.0016	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000253	0.0016	CcSEcCtD
Ticagrelor—Vomiting—Dexamethasone—ankylosing spondylitis	0.000251	0.00159	CcSEcCtD
Ticagrelor—Vomiting—Betamethasone—ankylosing spondylitis	0.000251	0.00159	CcSEcCtD
Ticagrelor—Rash—Betamethasone—ankylosing spondylitis	0.000249	0.00158	CcSEcCtD
Ticagrelor—Rash—Dexamethasone—ankylosing spondylitis	0.000249	0.00158	CcSEcCtD
Ticagrelor—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000249	0.00158	CcSEcCtD
Ticagrelor—Dermatitis—Betamethasone—ankylosing spondylitis	0.000249	0.00158	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000248	0.00157	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—ankylosing spondylitis	0.000248	0.00157	CcSEcCtD
Ticagrelor—Headache—Betamethasone—ankylosing spondylitis	0.000248	0.00157	CcSEcCtD
Ticagrelor—Headache—Dexamethasone—ankylosing spondylitis	0.000248	0.00157	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—ankylosing spondylitis	0.000247	0.00156	CcSEcCtD
Ticagrelor—Pruritus—Prednisone—ankylosing spondylitis	0.000244	0.00154	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000237	0.0015	CcSEcCtD
Ticagrelor—Diarrhoea—Prednisone—ankylosing spondylitis	0.000236	0.00149	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000235	0.00149	CcSEcCtD
Ticagrelor—Nausea—Dexamethasone—ankylosing spondylitis	0.000235	0.00149	CcSEcCtD
Ticagrelor—Nausea—Betamethasone—ankylosing spondylitis	0.000235	0.00149	CcSEcCtD
Ticagrelor—Dizziness—Prednisone—ankylosing spondylitis	0.000228	0.00144	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000227	0.00144	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000227	0.00144	CcSEcCtD
Ticagrelor—Vomiting—Prednisone—ankylosing spondylitis	0.000219	0.00138	CcSEcCtD
Ticagrelor—Rash—Prednisone—ankylosing spondylitis	0.000217	0.00137	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—ankylosing spondylitis	0.000217	0.00137	CcSEcCtD
Ticagrelor—Headache—Prednisone—ankylosing spondylitis	0.000216	0.00136	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000212	0.00134	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—ankylosing spondylitis	0.000206	0.00131	CcSEcCtD
Ticagrelor—Nausea—Prednisone—ankylosing spondylitis	0.000204	0.00129	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—ankylosing spondylitis	0.000204	0.00129	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000197	0.00125	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—ankylosing spondylitis	0.00019	0.0012	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—ankylosing spondylitis	0.000183	0.00116	CcSEcCtD
Ticagrelor—Rash—Methotrexate—ankylosing spondylitis	0.000181	0.00115	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—ankylosing spondylitis	0.000181	0.00115	CcSEcCtD
Ticagrelor—Headache—Methotrexate—ankylosing spondylitis	0.00018	0.00114	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—ankylosing spondylitis	0.000171	0.00108	CcSEcCtD
